Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Omnicell Inc (OMCL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,370,890
  • Shares Outstanding, K 41,219
  • Annual Sales, $ 787,310 K
  • Annual Income, $ 37,730 K
  • 60-Month Beta 1.20
  • Price/Sales 4.20
  • Price/Cash Flow 27.56
  • Price/Book 4.53

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate 0.47
  • Number of Estimates 4
  • High Estimate 0.47
  • Low Estimate 0.45
  • Prior Year 0.30
  • Growth Rate Est. (year over year) +56.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
72.58 +11.97%
on 04/23/19
84.41 -3.72%
on 05/03/19
+9.17 (+12.72%)
since 04/22/19
3-Month
70.06 +16.00%
on 04/17/19
86.87 -6.45%
on 03/04/19
-4.92 (-5.71%)
since 02/22/19
52-Week
45.15 +80.00%
on 05/29/18
86.87 -6.45%
on 03/04/19
+35.42 (+77.25%)
since 05/22/18

Most Recent Stories

More News
Will Omnicell (OMCL) Gain on Rising Earnings Estimates?

Omnicell (OMCL) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

OMCL : 81.27 (-0.62%)
Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?

Sector ETF report for PSCH

OMCL : 81.27 (-0.62%)
MMSI : 53.01 (-1.17%)
XLV : 89.15 (-0.09%)
VHT : 166.93 (-0.26%)
LHCG : 117.23 (-1.17%)
PSCH : 110.93 (-1.30%)
St. Luke's University Health Network Selects Omnicell to Enhance Efficiency and Safety in Medication Management

Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management and supply chain solutions for health systems, today announced that St. Luke's University Health Network, a non-profit,...

OMCL : 81.27 (-0.62%)
Omnicell Inc is Among the Companies in the Health Care Technology Industry with the Best Relative Performance (OMCL , EVH , TDOC , MDSO , VEEV )

We looked at the Health Care Technology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. ...

OMCL : 81.27 (-0.62%)
TDOC : 62.57 (-0.97%)
EVH : 14.52 (-0.14%)
NXGN vs. OMCL: Which Stock Should Value Investors Buy Now?

NXGN vs. OMCL: Which Stock Is the Better Value Option?

OMCL : 81.27 (-0.62%)
NXGN : 19.46 (-0.21%)
Omnicell (OMCL) Earnings and Revenues Beat Estimates in Q1

Omnicell (OMCL) gains from solid segmental contributions in Q1; margins expand.

OMCL : 81.27 (-0.62%)
ABT : 76.32 (+0.38%)
SYK : 185.80 (+0.19%)
CNMD : 80.58 (-0.09%)
Omnicell: 1Q Earnings Snapshot

MOUNTAIN VIEW, Calif. (AP) _ Omnicell Inc. (OMCL) on Thursday reported first-quarter earnings of $3.3 million.

OMCL : 81.27 (-0.62%)
Omnicell Reports Results for First Quarter 2019

Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions to healthcare systems, today announced results for its first quarter ended March 31, 2019.

OMCL : 81.27 (-0.62%)
Omnicell, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / April 25, 2019 / Omnicell, Inc. (NASDAQ: ) will be discussing their earnings results in their 2019 First Quarter Earnings to be held on April 25, 2019 at 4:30 PM Eastern Time....

OMCL : 81.27 (-0.62%)
The University of Tennessee Medical Center Selects Omnicell Solutions to Support Medication Management Strategy

Omnicell, Inc. (NASDAQ:OMCL) today announced that The University of Tennessee Medical Center in Knoxville will expand its Omnicell® automated medication management platform with the addition of new automation...

OMCL : 81.27 (-0.62%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade OMCL with:

Business Summary

Omnicell, Inc. is a leading provider of medication and supply management automation, analytics software, and medication adherence solutions for healthcare organizations. It works with healthcare providers to drive operational efficiency by removing tedious tasks and waste. Regardless of distribution...

See More

Key Turning Points

2nd Resistance Point 83.52
1st Resistance Point 82.65
Last Price 81.27
1st Support Level 80.50
2nd Support Level 79.23

See More

52-Week High 86.87
Last Price 81.27
Fibonacci 61.8% 70.93
Fibonacci 50% 66.01
Fibonacci 38.2% 61.09
52-Week Low 45.15

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar